Predictor and Saverity Caries in HIV/AIDS Patient and Relationship with Antiretroviral Therapy (ARV)

Article Sidebar

PDF
Published: Nov 4, 2021
DOI: https://doi.org/10.47191/ijmscrs/v1-i9-02
Keywords:
Antiretroviral, Caries Predictor, Caries Severity

Main Article Content

Surya Irayani
Dental Nurse Department Health of Polytechnic
Hans Lesmana
Dental Nurse Department Health of Polytechnic
Rini Sitanaya
Dental Nurse Department Health of Polytechnic
Aco Tang
Physiotherapy Department Health of Polytechnic
Fatimah Gobel
Faculty of Public Health, Moslem Indonesia University

Abstract

Clinical findings about the adverse effects of the use of antiretroviral drugs in the oral cavity of people with HIV / AIDS began to be found. A case regarding the side effects of the use of antiretroviral drugs is the discovery of oral cavity lesions in the form of whitish plaque on the lips and right buccal mucosa that has occurred more than one month accompanied by complaints of taste disorders, xerostomia, and a burning feeling in the mucosa of patients using Nevirapine, Zidovudine and Lamivudine. This study was to analyze the relationship of anti-retroviral treatment in HIV AIDS sufferers to caries predictors, and caries severity, and analyze the relationship between the duration of antiretroviral treatment to caries predictors and caries severity. This study used an observational method with cross sectional or cross sectional design by conducting direct observations, on 100 samples of HIV / AIDS sufferers using anti-retroviral drugs at the Yayasan Peduli Kelompok Dukungan Sebaya (YPKDS) Makassar held in October 2019. Data were analyzed with chi square test.


The results obtained that there is a relationship between antiretroviral treatment in HIV / AIDS patients with caries predictors (p = 0.357) and caries severity (p = 0.005), while analysis of the duration of antiretroviral treatment is less than 5 years and more than 5 years there is no relationship with caries predictors (p = 0.730) and caries severity (p = 0.428).

Article Details

How to Cite
Surya Irayani, Hans Lesmana, Rini Sitanaya, Aco Tang, & Fatimah Gobel. (2021). Predictor and Saverity Caries in HIV/AIDS Patient and Relationship with Antiretroviral Therapy (ARV) . International Journal of Medical Science and Clinical Research Studies, 1(9), 257–262. https://doi.org/10.47191/ijmscrs/v1-i9-02
Issue
Vol. 1 No. 9 (2021): Volume 01 Issue 09 November 2021
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. S. R. Flint, A. Tappuni, J. Leigh, A.-M. Schmidt-Westhausen, and L. MacPhail, “(B3) Markers of immunodeficiency and mechanisms of HAART therapy on oral lesions,” Adv. Dent. Res., vol. 19, no. 1, pp. 146–151, 2006.

II. H. F. Chambers, S. J. McPhee, M. A. Papadakis, and L. M. Tierney, “Current medical diagnosis and treatment.” McGraw-Hill Medical, 2008.

III. M. D. Moura, M. I. Senna, D. F. Madureira, L. M. Fonseca, and R. A. Mesquita, “Oral adverse effects due to the use of Nevirapine.,” J. Contemp. Dent. Pract., vol. 9, no. 1, pp. 84–90, 2008.

IV. S. G. P. Sari L M, “Manifestasi Sindroma Stevens-Johnson Akibat Obat Antiretroviral Nevirapine Pada Pasien Acquired Immunodeficiency Syndrome (AIDS),” Dentika Dent. J., vol. 11, no. 2, p. 171, 2006.

V. A. Olive, A. Salavert, M. Manriques, B. Clotet, and A. Moragas, “Parotid lipomatosis in HIV positive patients: a new clinical disorder associated with protease inhibitors,” Ann. Rheum. Dis., vol. 57, no. 12, p. 749, 1998.

VI. R. P. Langlais and C. S. Miller, “Atlas Bewarna Kelainan Rongga Mulut yang Lazim,” 2000.

VII. J. M. Plemons, I. Al-Hashimi, and C. L. Marek, “Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs,” J. Am. Dent. Assoc., vol. 145, no. 8, pp. 867–873, 2014.

VIII. E. A. M. Kidd and O. Fejerskov, Essentials of dental caries. Oxford University Press, 2016.

IX. Tarigan, Karies gigi edisi 2. Elsevier, 2013.

X. J. Frencken, E. Van Amerogen, P. Phantumvanit, Y. Songpaisan, and T. Pilot, “Manual for the Atraumatic Restaurative Treatment approach to control dental caries,” Dent. Heal. Int. Nederlant. ISBN90-803296-1-4, 1997.

XI. S. R. Ponnam, G. Srivastava, and K. Theruru, “Oral manifestations of human immunodeficiency virus in children: An institutional study at highly active antiretroviral therapy centre in India,” J. oral Maxillofac. Pathol. JOMFP, vol. 16, no. 2, p. 195, 2012.

XII. L. Rezaei-Soufi, P. Davoodi, H. R. Abdolsamadi, M. Jazaeri, and H. Malekzadeh, “Dental caries prevalence in human immunodeficiency virus infected patients receiving highly active anti-retroviral therapy in kermanshah, Iran,” Cell J., vol. 16, no. 1, p. 73, 2014.

XIII. A. P. Nugraha et al., “Correlation of Low CD4+ Counts with High Dental Caries Prevalence in Children Living with Perinatal HIV/AIDS Undergoing Antiretroviral Therapy,” Pesqui. Bras. Odontopediatria Clin. Integr., vol. 19, p. 4819, 2019.

XIV. D. Kalanzi, H. Mayanja-Kizza, D. Nakanjako, C. L. Mwesigwa, R. Ssenyonga, and B. T. Amaechi, “Prevalence and factors associated with dental caries in patients attending an HIV care clinic in Uganda: a cross sectional study,” BMC Oral Health, vol. 19, no. 1, p. 159, 2019.